BUCK ELIZABETH (Chief Scientific Officer) received a stock award from BLACK DIAMOND THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/31/2025ACC: 0001415889-25-002492
Officer· Chief Scientific Officer
Since Sep 2021
+250K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
250K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+75K
Price / share
—
Trade value
—
% of position
78.8%
1/30/2025
95.19K→170.19K
Total
Net shares
+75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2025 | A · Award | +75K | — | — | 78.8% | 95.19K | 170.19K |
| Total | +75K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
175K shares
Shares
+175K
Strike price
2.52
Held after
175K
Exercisable
—
1/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock175K shares | 1/30/2025 | A · Award | +175K | 2.52 | — | 175K |